Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
作者： Elizabeth A. Sadowski , Lindsey K. Bennett , Micah R. Chan , Andrew L. Wentland , Andrea L. Garrett
DOI: 10.1148/RADIOL.2431062144
关键词:
摘要: Purpose: To retrospectively review data in 13 patients with biopsy-confirmed nephrogenic systemic fibrosis (NSF), assess the associated risk factors, and report incidence of NSF at authors' institution. Materials Methods: This HIPAA-compliant study had institutional board approval; informed consent was waived. Statistical analysis performed for all available clinical laboratory NSF. The from were compared a control population renal insufficiency but who did not develop Results: There eight male five female patients, aged 17–69 years, diagnosis Within 6 months diagnosis, been exposed to gadodiamide one gadobenate dimeglumine addition gadodiamide. At time contrast material–enhanced magnetic resonance (MR) imaging, (estimated glomerular filtration rate [eGFR]...
rsna.org
rsnajnls.org参考文章(26)
Joshua M. Levine, Robert A. Taylor, Lauren B. Elman, Shawn J. Bird, Ehud Lavi, Ethan D. Stolzenberg, Michael L. McGarvey, Arthur K. Asbury, Sergio A. Jimenez, Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Muscle & Nerve. ,vol. 30, pp. 569- 577 ,(2004) , 10.1002/MUS.20153
Shawn E. Cowper, Nephrogenic fibrosing dermopathy: the first 6 years. Current Opinion in Rheumatology. ,vol. 15, pp. 785- 790 ,(2003) , 10.1097/00002281-200311000-00017
Julian M. Mackay-Wiggan, David J. Cohen, Mark A. Hardy, Elizabeth H. Knobler, Marc E. Grossman, Nephrogenic fibrosing dermopathy (scleromyxedema-like illness of renal disease). Journal of The American Academy of Dermatology. ,vol. 48, pp. 55- 60 ,(2003) , 10.1067/MJD.2003.78
Scott M. Rocklage, Dilip Worah, Sook-Hui Kim, Metal ion release from paramagnetic chelates: what is tolerable? Magnetic Resonance in Medicine. ,vol. 22, pp. 216- 221 ,(1991) , 10.1002/MRM.1910220211
Anjela Galan, Shawn E Cowper, Richard Bucala, Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy). Current Opinion in Rheumatology. ,vol. 18, pp. 614- 617 ,(2006) , 10.1097/01.BOR.0000245725.94887.8D
Henrik S Thomsen, European Society of Urogenital Radiology guidelines on contrast media application. Current Opinion in Urology. ,vol. 17, pp. 70- 76 ,(2007) , 10.1097/MOU.0B013E328011C96F
Audun N. Oksendal, Petter-Arnt Hals, Biodistribution and toxicity of MR imaging contrast media. Journal of Magnetic Resonance Imaging. ,vol. 3, pp. 157- 165 ,(1993) , 10.1002/JMRI.1880030128
Gunter Wolf, Sheldon Chen, Dong Cheol Han, Fuad N. Ziyadeh, Leptin and renal disease American Journal of Kidney Diseases. ,vol. 39, pp. 1- 11 ,(2002) , 10.1053/AJKD.2002.29865
Sundararaman Swaminathan, Nelson Leung, Nephrogenic fibrosing dermopathy: lessons from the past. International Journal of Dermatology. ,vol. 45, pp. 639- 641 ,(2006) , 10.1111/J.1365-4632.2006.02837.X
Shawn E. Cowper, Nephrogenic systemic fibrosis: the nosological and conceptual evolution of nephrogenic fibrosing dermopathy. American Journal of Kidney Diseases. ,vol. 46, pp. 763- 765 ,(2005) , 10.1053/J.AJKD.2005.08.008